25 XP   0   0   10

Fresenius SE & Co KGaA ADR
Buy, Hold or Sell?

Let's analyse Fresenius together

PenkeI guess you are interested in Fresenius SE & Co KGaA ADR. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Fresenius SE & Co KGaA ADR. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Fresenius SE & Co KGaA ADR

I send you an email if I find something interesting about Fresenius SE & Co KGaA ADR.

Quick analysis of Fresenius (30 sec.)










What can you expect buying and holding a share of Fresenius? (30 sec.)

How much money do you get?

How much money do you get?
$0.58
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
$8.72
Expected worth in 1 year
$3.14
How sure are you?
82.5%

+ What do you gain per year?

Total Gains per Share
$-5.00
Return On Investment
-70.3%

For what price can you sell your share?

Current Price per Share
$7.11
Expected price per share
$6.57 - $7.52
How sure are you?
50%

1. Valuation of Fresenius (5 min.)




Live pricePrice per Share (EOD)

$7.11

Intrinsic Value Per Share

$9.87 - $18.69

Total Value Per Share

$18.59 - $27.41

2. Growth of Fresenius (5 min.)




Is Fresenius growing?

Current yearPrevious yearGrowGrow %
How rich?$19.6b$32.2b-$3.8b-13.6%

How much money is Fresenius making?

Current yearPrevious yearGrowGrow %
Making money-$126.9m$563.4m-$690.3m-543.8%
Net Profit Margin-3.2%5.2%--

How much money comes from the company's main activities?

3. Financial Health of Fresenius (5 min.)




4. Comparing to competitors in the Medical Care Facilities industry (5 min.)




  Industry Rankings (Medical Care Facilities)  


Richest
#2 / 187

Most Revenue
#3 / 187

Most Profit
#183 / 187

Most Efficient
#136 / 187

What can you expect buying and holding a share of Fresenius? (5 min.)

Welcome investor! Fresenius's management wants to use your money to grow the business. In return you get a share of Fresenius.

What can you expect buying and holding a share of Fresenius?

First you should know what it really means to hold a share of Fresenius. And how you can make/lose money.

Speculation

The Price per Share of Fresenius is $7.11. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Fresenius.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Fresenius, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $8.72. Based on the TTM, the Book Value Change Per Share is $-1.39 per quarter. Based on the YOY, the Book Value Change Per Share is $0.33 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.15 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Fresenius.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.29-4.1%-0.10-1.4%0.162.3%0.142.0%0.131.9%
Usd Book Value Change Per Share-4.70-66.1%-1.39-19.6%0.334.6%-0.12-1.7%0.070.9%
Usd Dividend Per Share0.000.0%0.152.0%0.111.5%0.121.7%0.111.5%
Usd Total Gains Per Share-4.70-66.1%-1.25-17.6%0.436.1%0.000.1%0.172.4%
Usd Price Per Share7.73-7.30-7.30-10.12-13.97-
Price to Earnings Ratio-6.66-18.34-11.41-14.44-323.31-
Price-to-Total Gains Ratio-1.64-351.71-5.06-31.95-57.07-
Price to Book Ratio0.89-0.61-0.51-0.83-1.46-
Price-to-Total Gains Ratio-1.64-351.71-5.06-31.95-57.07-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share7.11
Number of shares140
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.150.12
Usd Book Value Change Per Share-1.39-0.12
Usd Total Gains Per Share-1.250.00
Gains per Quarter (140 shares)-174.890.55
Gains per Year (140 shares)-699.582.22
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
181-781-71069-67-8
2163-1562-1410138-133-6
3244-2343-2110206-200-4
4325-3124-2810275-266-2
5407-3905-3510344-3330
6488-4686-4210413-3992
7569-5466-4910482-4664
8651-6247-5610550-5336
9732-7028-6310619-5998
10813-7809-7010688-66610

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share2.02.00.050.0%10.02.00.083.3%18.02.00.090.0%38.02.00.095.0%58.02.00.096.7%
Book Value Change Per Share0.04.00.00.0%6.06.00.050.0%10.010.00.050.0%28.012.00.070.0%41.016.03.068.3%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%60.00.00.0100.0%
Total Gains per Share2.02.00.050.0%9.03.00.075.0%14.06.00.070.0%33.07.00.082.5%51.09.00.085.0%

Fundamentals of Fresenius

About Fresenius SE & Co KGaA ADR

Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, dialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients. This segment offers I.V. generic drugs; biosimilar drugs for autoimmune diseases and oncology; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The Fresenius Vamed segment provides services for hospitals and other healthcare facilities. This segment also offers operational management of healthcare facilities and provides services to patients. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.

Fundamental data was last updated by Penke on 2024-03-31 04:40:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Fresenius SE & Co KGaA ADR.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Fresenius earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Fresenius to the Medical Care Facilities industry mean.
  • A Net Profit Margin of -10.8% means that $-0.11 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Fresenius SE & Co KGaA ADR:

  • The MRQ is -10.8%. The company is making a huge loss. -2
  • The TTM is -3.2%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ-10.8%TTM-3.2%-7.6%
TTM-3.2%YOY5.2%-8.4%
TTM-3.2%5Y3.4%-6.6%
5Y3.4%10Y4.3%-1.0%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ-10.8%2.5%-13.3%
TTM-3.2%2.6%-5.8%
YOY5.2%3.8%+1.4%
5Y3.4%3.3%+0.1%
10Y4.3%3.7%+0.6%
1.1.2. Return on Assets

Shows how efficient Fresenius is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Fresenius to the Medical Care Facilities industry mean.
  • -1.4% Return on Assets means that Fresenius generated $-0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Fresenius SE & Co KGaA ADR:

  • The MRQ is -1.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -0.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-1.4%TTM-0.3%-1.1%
TTM-0.3%YOY0.7%-1.1%
TTM-0.3%5Y0.5%-0.8%
5Y0.5%10Y0.7%-0.2%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.4%0.8%-2.2%
TTM-0.3%0.7%-1.0%
YOY0.7%1.2%-0.5%
5Y0.5%1.1%-0.6%
10Y0.7%1.3%-0.6%
1.1.3. Return on Equity

Shows how efficient Fresenius is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Fresenius to the Medical Care Facilities industry mean.
  • -3.4% Return on Equity means Fresenius generated $-0.03 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Fresenius SE & Co KGaA ADR:

  • The MRQ is -3.4%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -0.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-3.4%TTM-0.7%-2.7%
TTM-0.7%YOY2.7%-3.4%
TTM-0.7%5Y2.1%-2.8%
5Y2.1%10Y2.8%-0.7%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.4%2.4%-5.8%
TTM-0.7%2.4%-3.1%
YOY2.7%3.0%-0.3%
5Y2.1%2.7%-0.6%
10Y2.8%2.8%+0.0%

1.2. Operating Efficiency of Fresenius SE & Co KGaA ADR.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Fresenius is operating .

  • Measures how much profit Fresenius makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Fresenius to the Medical Care Facilities industry mean.
  • An Operating Margin of 3.2% means the company generated $0.03  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Fresenius SE & Co KGaA ADR:

  • The MRQ is 3.2%. The company is operating less efficient.
  • The TTM is 8.1%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ3.2%TTM8.1%-4.8%
TTM8.1%YOY8.6%-0.5%
TTM8.1%5Y10.8%-2.7%
5Y10.8%10Y12.6%-1.8%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ3.2%6.7%-3.5%
TTM8.1%6.7%+1.4%
YOY8.6%7.4%+1.2%
5Y10.8%6.8%+4.0%
10Y12.6%8.2%+4.4%
1.2.2. Operating Ratio

Measures how efficient Fresenius is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Care Facilities industry mean).
  • An Operation Ratio of 0.97 means that the operating costs are $0.97 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Fresenius SE & Co KGaA ADR:

  • The MRQ is 0.968. The company is less efficient in keeping operating costs low.
  • The TTM is 0.944. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.968TTM0.944+0.024
TTM0.944YOY0.918+0.026
TTM0.9445Y0.900+0.044
5Y0.90010Y0.881+0.019
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9681.163-0.195
TTM0.9441.112-0.168
YOY0.9181.014-0.096
5Y0.9001.023-0.123
10Y0.8811.004-0.123

1.3. Liquidity of Fresenius SE & Co KGaA ADR.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Fresenius is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Care Facilities industry mean).
  • A Current Ratio of 1.34 means the company has $1.34 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Fresenius SE & Co KGaA ADR:

  • The MRQ is 1.342. The company is just able to pay all its short-term debts.
  • The TTM is 1.320. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.342TTM1.320+0.022
TTM1.320YOY1.309+0.011
TTM1.3205Y1.194+0.126
5Y1.19410Y1.261-0.067
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3421.289+0.053
TTM1.3201.311+0.009
YOY1.3091.405-0.096
5Y1.1941.382-0.188
10Y1.2611.416-0.155
1.3.2. Quick Ratio

Measures if Fresenius is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Fresenius to the Medical Care Facilities industry mean.
  • A Quick Ratio of 0.92 means the company can pay off $0.92 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Fresenius SE & Co KGaA ADR:

  • The MRQ is 0.921. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.882. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.921TTM0.882+0.039
TTM0.882YOY0.762+0.120
TTM0.8825Y0.747+0.135
5Y0.74710Y0.778-0.032
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9210.9210.000
TTM0.8820.950-0.068
YOY0.7621.074-0.312
5Y0.7471.158-0.411
10Y0.7781.146-0.368

1.4. Solvency of Fresenius SE & Co KGaA ADR.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Fresenius assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Fresenius to Medical Care Facilities industry mean.
  • A Debt to Asset Ratio of 0.57 means that Fresenius assets are financed with 56.6% credit (debt) and the remaining percentage (100% - 56.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Fresenius SE & Co KGaA ADR:

  • The MRQ is 0.566. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.583. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.566TTM0.583-0.017
TTM0.583YOY0.579+0.005
TTM0.5835Y0.596-0.013
5Y0.59610Y0.586+0.009
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5660.521+0.045
TTM0.5830.547+0.036
YOY0.5790.516+0.063
5Y0.5960.560+0.036
10Y0.5860.534+0.052
1.4.2. Debt to Equity Ratio

Measures if Fresenius is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Fresenius to the Medical Care Facilities industry mean.
  • A Debt to Equity ratio of 134.9% means that company has $1.35 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Fresenius SE & Co KGaA ADR:

  • The MRQ is 1.349. The company is able to pay all its debts with equity. +1
  • The TTM is 2.000. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.349TTM2.000-0.650
TTM2.000YOY2.149-0.150
TTM2.0005Y2.271-0.271
5Y2.27110Y2.280-0.009
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3490.916+0.433
TTM2.0000.952+1.048
YOY2.1491.008+1.141
5Y2.2711.244+1.027
10Y2.2801.253+1.027

2. Market Valuation of Fresenius SE & Co KGaA ADR

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Fresenius generates.

  • Above 15 is considered overpriced but always compare Fresenius to the Medical Care Facilities industry mean.
  • A PE ratio of -6.66 means the investor is paying $-6.66 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Fresenius SE & Co KGaA ADR:

  • The EOD is -6.126. Based on the earnings, the company is expensive. -2
  • The MRQ is -6.661. Based on the earnings, the company is expensive. -2
  • The TTM is 18.339. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD-6.126MRQ-6.661+0.534
MRQ-6.661TTM18.339-24.999
TTM18.339YOY11.414+6.925
TTM18.3395Y14.441+3.898
5Y14.44110Y323.311-308.870
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
EOD-6.12611.438-17.564
MRQ-6.66110.518-17.179
TTM18.33914.051+4.288
YOY11.41411.500-0.086
5Y14.44116.455-2.014
10Y323.31120.280+303.031
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Fresenius SE & Co KGaA ADR:

  • The EOD is 2.946. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 3.203. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is -0.576. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD2.946MRQ3.203-0.257
MRQ3.203TTM-0.576+3.779
TTM-0.576YOY-1.331+0.754
TTM-0.5765Y5.472-6.049
5Y5.47210Y-50.212+55.684
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
EOD2.9468.429-5.483
MRQ3.2037.334-4.131
TTM-0.5767.397-7.973
YOY-1.3316.543-7.874
5Y5.4726.849-1.377
10Y-50.2125.564-55.776
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Fresenius is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Care Facilities industry mean).
  • A PB ratio of 0.89 means the investor is paying $0.89 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Fresenius SE & Co KGaA ADR:

  • The EOD is 0.815. Based on the equity, the company is cheap. +2
  • The MRQ is 0.886. Based on the equity, the company is cheap. +2
  • The TTM is 0.609. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.815MRQ0.886-0.071
MRQ0.886TTM0.609+0.278
TTM0.609YOY0.514+0.094
TTM0.6095Y0.830-0.221
5Y0.83010Y1.456-0.626
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
EOD0.8151.883-1.068
MRQ0.8862.033-1.147
TTM0.6092.063-1.454
YOY0.5142.286-1.772
5Y0.8302.388-1.558
10Y1.4562.658-1.202
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Fresenius SE & Co KGaA ADR compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---4.703-1.395-70%0.325-1547%-0.119-97%0.066-7261%
Book Value Per Share--8.72212.595-31%14.314-39%12.551-31%10.637-18%
Current Ratio--1.3421.320+2%1.309+3%1.194+12%1.261+6%
Debt To Asset Ratio--0.5660.583-3%0.579-2%0.596-5%0.586-3%
Debt To Equity Ratio--1.3492.000-33%2.149-37%2.271-41%2.280-41%
Dividend Per Share--0.0030.145-98%0.105-97%0.123-98%0.106-97%
Eps---0.290-0.102-65%0.162-279%0.140-307%0.132-320%
Free Cash Flow Per Share--0.6030.365+65%0.269+124%0.287+110%0.160+278%
Free Cash Flow To Equity Per Share--0.6090.203+200%0.080+661%0.097+525%0.073+734%
Gross Profit Margin--2.2211.305+70%0.243+814%0.576+286%0.565+293%
Intrinsic Value_10Y_max--18.689--------
Intrinsic Value_10Y_min--9.868--------
Intrinsic Value_1Y_max--1.404--------
Intrinsic Value_1Y_min--0.703--------
Intrinsic Value_3Y_max--4.577--------
Intrinsic Value_3Y_min--2.372--------
Intrinsic Value_5Y_max--8.179--------
Intrinsic Value_5Y_min--4.313--------
Market Cap16018474613.760-9%17415303623.68016440357683.570+6%16435270366.720+6%22808137389.092-24%31476163624.594-45%
Net Profit Margin---0.108-0.032-70%0.052-307%0.034-421%0.043-350%
Operating Margin--0.0320.081-60%0.086-62%0.108-70%0.126-74%
Operating Ratio--0.9680.944+3%0.918+5%0.900+7%0.881+10%
Pb Ratio0.815-9%0.8860.609+46%0.514+72%0.830+7%1.456-39%
Pe Ratio-6.126+8%-6.66118.339-136%11.414-158%14.441-146%323.311-102%
Price Per Share7.110-9%7.7307.295+6%7.295+6%10.123-24%13.971-45%
Price To Free Cash Flow Ratio2.946-9%3.203-0.576+118%-1.331+142%5.472-41%-50.212+1668%
Price To Total Gains Ratio-1.513+8%-1.645351.705-100%5.060-133%31.953-105%57.067-103%
Quick Ratio--0.9210.882+4%0.762+21%0.747+23%0.778+18%
Return On Assets---0.014-0.003-78%0.007-296%0.005-385%0.007-306%
Return On Equity---0.034-0.007-80%0.027-226%0.021-265%0.028-223%
Total Gains Per Share---4.700-1.249-73%0.430-1192%0.004-118750%0.172-2835%
Usd Book Value--19651000000.00028384000000.000-31%32247750000.000-39%28278300000.000-31%23965550000.000-18%
Usd Book Value Change Per Share---4.703-1.395-70%0.325-1547%-0.119-97%0.066-7261%
Usd Book Value Per Share--8.72212.595-31%14.314-39%12.551-31%10.637-18%
Usd Dividend Per Share--0.0030.145-98%0.105-97%0.123-98%0.106-97%
Usd Eps---0.290-0.102-65%0.162-279%0.140-307%0.132-320%
Usd Free Cash Flow--1359494200.000821871200.000+65%607088150.000+124%646638040.000+110%359834800.000+278%
Usd Free Cash Flow Per Share--0.6030.365+65%0.269+124%0.287+110%0.160+278%
Usd Free Cash Flow To Equity Per Share--0.6090.203+200%0.080+661%0.097+525%0.073+734%
Usd Market Cap16018474613.760-9%17415303623.68016440357683.570+6%16435270366.720+6%22808137389.092-24%31476163624.594-45%
Usd Price Per Share7.110-9%7.7307.295+6%7.295+6%10.123-24%13.971-45%
Usd Profit---653664400.000-126953550.000-81%563439550.000-216%375165040.000-274%396749805.000-265%
Usd Revenue--6044798800.0008458247000.000-29%10869566000.000-44%9678597980.000-38%8761178930.000-31%
Usd Total Gains Per Share---4.700-1.249-73%0.430-1192%0.004-118750%0.172-2835%
 EOD+4 -4MRQTTM+14 -22YOY+14 -225Y+13 -2310Y+13 -23

3.2. Fundamental Score

Let's check the fundamental score of Fresenius SE & Co KGaA ADR based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-6.126
Price to Book Ratio (EOD)Between0-10.815
Net Profit Margin (MRQ)Greater than0-0.108
Operating Margin (MRQ)Greater than00.032
Quick Ratio (MRQ)Greater than10.921
Current Ratio (MRQ)Greater than11.342
Debt to Asset Ratio (MRQ)Less than10.566
Debt to Equity Ratio (MRQ)Less than11.349
Return on Equity (MRQ)Greater than0.15-0.034
Return on Assets (MRQ)Greater than0.05-0.014
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Fresenius SE & Co KGaA ADR based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5060.409
Ma 20Greater thanMa 506.823
Ma 50Greater thanMa 1006.884
Ma 100Greater thanMa 2007.211
OpenGreater thanClose7.106
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Income before Tax  590,85366,005656,858-274,667382,191-120,300261,892-304,476-42,584
Net Income from Continuing Operations  429,03463,876492,910-316,186176,724-11,711165,013-396,031-231,018



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets45,284,000
Total Liabilities25,633,000
Total Stockholder Equity18,999,000
 As reported
Total Liabilities 25,633,000
Total Stockholder Equity+ 18,999,000
Total Assets = 45,284,000

Assets

Total Assets45,284,000
Total Current Assets12,520,000
Long-term Assets32,764,000
Total Current Assets
Cash And Cash Equivalents 2,562,000
Net Receivables 6,027,000
Inventory 2,517,000
Other Current Assets 1,414,000
Total Current Assets  (as reported)12,520,000
Total Current Assets  (calculated)12,520,000
+/-0
Long-term Assets
Property Plant Equipment 10,782,000
Goodwill 15,089,000
Intangible Assets 2,531,000
Long-term Assets Other 396,000
Long-term Assets  (as reported)32,764,000
Long-term Assets  (calculated)28,798,000
+/- 3,966,000

Liabilities & Shareholders' Equity

Total Current Liabilities9,330,000
Long-term Liabilities16,303,000
Total Stockholder Equity18,999,000
Total Current Liabilities
Short-term Debt 2,581,000
Short Long Term Debt 2,375,000
Accounts payable 1,488,000
Other Current Liabilities 4,958,000
Total Current Liabilities  (as reported)9,330,000
Total Current Liabilities  (calculated)11,402,000
+/- 2,072,000
Long-term Liabilities
Long term Debt 11,457,000
Capital Lease Obligations 1,998,000
Long-term Liabilities Other 140,000
Long-term Liabilities  (as reported)16,303,000
Long-term Liabilities  (calculated)13,595,000
+/- 2,708,000
Total Stockholder Equity
Common Stock563,000
Retained Earnings 14,092,000
Accumulated Other Comprehensive Income 18,000
Other Stockholders Equity 4,326,000
Total Stockholder Equity (as reported)18,999,000
Total Stockholder Equity (calculated)18,999,000
+/-0
Other
Capital Stock563,000
Cash and Short Term Investments 2,562,000
Common Stock Shares Outstanding 563,237
Current Deferred Revenue303,000
Liabilities and Stockholders Equity 45,284,000
Net Debt 13,268,000
Net Invested Capital 32,831,000
Net Working Capital 3,190,000
Property Plant and Equipment Gross 17,580,000
Short Long Term Debt Total 15,830,000



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-31
> Total Assets 
0
0
0
20,882,000
22,048,000
23,907,000
22,734,000
23,577,000
23,572,000
23,909,000
24,707,000
26,321,000
28,542,000
30,758,000
30,225,000
30,664,000
31,311,000
30,973,000
30,678,000
32,758,000
34,284,000
35,502,000
37,718,000
39,897,000
43,032,000
42,271,000
42,169,000
43,170,000
42,445,000
43,821,000
44,075,000
46,447,000
54,418,000
52,897,000
53,097,000
53,133,000
53,502,000
54,982,000
55,723,000
56,703,000
64,985,000
64,929,000
66,759,000
67,006,000
68,972,000
69,554,000
68,321,000
66,646,000
68,966,000
69,655,000
71,081,000
71,962,000
73,114,000
76,112,000
80,328,000
76,415,000
76,553,000
76,413,000
75,328,000
45,284,000
45,284,00075,328,00076,413,00076,553,00076,415,00080,328,00076,112,00073,114,00071,962,00071,081,00069,655,00068,966,00066,646,00068,321,00069,554,00068,972,00067,006,00066,759,00064,929,00064,985,00056,703,00055,723,00054,982,00053,502,00053,133,00053,097,00052,897,00054,418,00046,447,00044,075,00043,821,00042,445,00043,170,00042,169,00042,271,00043,032,00039,897,00037,718,00035,502,00034,284,00032,758,00030,678,00030,973,00031,311,00030,664,00030,225,00030,758,00028,542,00026,321,00024,707,00023,909,00023,572,00023,577,00022,734,00023,907,00022,048,00020,882,000000
   > Total Current Assets 
0
0
0
5,363,000
5,795,000
6,474,000
6,392,000
6,435,000
6,808,000
6,752,000
6,836,000
7,151,000
7,682,000
8,967,000
8,621,000
8,113,000
8,267,000
8,257,000
8,188,000
7,972,000
8,656,000
9,464,000
9,584,000
10,028,000
10,688,000
10,513,000
10,550,000
10,917,000
10,584,000
11,000,000
11,135,000
11,799,000
13,077,000
12,799,000
12,870,000
12,604,000
13,409,000
14,287,000
14,593,000
14,790,000
14,958,000
14,851,000
15,180,000
15,264,000
16,341,000
17,153,000
16,833,000
15,772,000
16,693,000
16,901,000
17,334,000
17,461,000
18,002,000
18,818,000
19,443,000
18,279,000
19,102,000
19,305,000
44,835,000
12,520,000
12,520,00044,835,00019,305,00019,102,00018,279,00019,443,00018,818,00018,002,00017,461,00017,334,00016,901,00016,693,00015,772,00016,833,00017,153,00016,341,00015,264,00015,180,00014,851,00014,958,00014,790,00014,593,00014,287,00013,409,00012,604,00012,870,00012,799,00013,077,00011,799,00011,135,00011,000,00010,584,00010,917,00010,550,00010,513,00010,688,00010,028,0009,584,0009,464,0008,656,0007,972,0008,188,0008,257,0008,267,0008,113,0008,621,0008,967,0007,682,0007,151,0006,836,0006,752,0006,808,0006,435,0006,392,0006,474,0005,795,0005,363,000000
       Cash And Cash Equivalents 
0
0
0
420,000
467,000
608,000
660,000
769,000
894,000
608,000
654,000
635,000
855,000
1,015,000
968,000
885,000
850,000
842,000
873,000
864,000
829,000
1,070,000
1,035,000
1,175,000
992,000
917,000
975,000
1,044,000
882,000
1,098,000
1,185,000
1,579,000
1,480,000
1,371,000
1,472,000
1,636,000
1,484,000
2,267,000
2,456,000
2,709,000
1,543,000
1,463,000
1,599,000
1,654,000
2,028,000
3,073,000
2,658,000
1,837,000
1,877,000
2,250,000
2,413,000
2,610,000
2,077,000
2,129,000
2,128,000
2,175,000
2,321,000
2,471,000
1,095,000
2,562,000
2,562,0001,095,0002,471,0002,321,0002,175,0002,128,0002,129,0002,077,0002,610,0002,413,0002,250,0001,877,0001,837,0002,658,0003,073,0002,028,0001,654,0001,599,0001,463,0001,543,0002,709,0002,456,0002,267,0001,484,0001,636,0001,472,0001,371,0001,480,0001,579,0001,185,0001,098,000882,0001,044,000975,000917,000992,0001,175,0001,035,0001,070,000829,000864,000873,000842,000850,000885,000968,0001,015,000855,000635,000654,000608,000894,000769,000660,000608,000467,000420,000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
68,000
0
0
0
43,000
0
0
0
0
0
0
0
0
0
0
0
30,000
0
0
0
9,000
0
0
0
100,000
0
0
0
133,000
0
0
0
161,000
0
0
0
136,000
0
0
0
170,000
0
0
0
0
0000170,000000136,000000161,000000133,000000100,0000009,00000030,0000000000000043,00000068,000000000000000000
       Net Receivables 
0
0
0
2,815,000
2,985,000
3,246,000
2,914,000
3,330,000
3,415,000
3,506,000
3,501,000
3,615,000
3,915,000
3,939,000
3,931,000
4,776,000
4,178,000
4,090,000
3,952,000
4,577,000
4,084,000
4,293,000
4,480,000
5,932,000
5,224,000
5,084,000
5,129,000
6,379,000
4,903,000
4,841,000
4,958,000
6,378,000
6,298,000
5,951,000
6,105,000
7,192,000
6,875,000
6,756,000
6,591,000
8,285,000
7,445,000
7,227,000
7,222,000
9,291,000
7,802,000
7,329,000
7,304,000
9,302,000
7,776,000
7,497,000
7,553,000
9,933,000
7,983,000
8,015,000
8,146,000
10,256,000
7,869,000
7,758,000
37,681,000
6,027,000
6,027,00037,681,0007,758,0007,869,00010,256,0008,146,0008,015,0007,983,0009,933,0007,553,0007,497,0007,776,0009,302,0007,304,0007,329,0007,802,0009,291,0007,222,0007,227,0007,445,0008,285,0006,591,0006,756,0006,875,0007,192,0006,105,0005,951,0006,298,0006,378,0004,958,0004,841,0004,903,0006,379,0005,129,0005,084,0005,224,0005,932,0004,480,0004,293,0004,084,0004,577,0003,952,0004,090,0004,178,0004,776,0003,931,0003,939,0003,915,0003,615,0003,501,0003,506,0003,415,0003,330,0002,914,0003,246,0002,985,0002,815,000000
       Other Current Assets 
0
0
0
893,000
979,000
1,117,000
1,420,000
925,000
1,010,000
1,090,000
1,069,000
1,184,000
1,115,000
2,158,000
1,966,000
544,000
1,278,000
1,328,000
1,377,000
474,000
1,563,000
1,824,000
1,731,000
588,000
1,824,000
1,859,000
1,696,000
634,000
1,929,000
2,075,000
1,940,000
623,000
2,027,000
2,282,000
2,129,000
515,000
2,116,000
2,188,000
2,367,000
478,000
2,461,000
2,560,000
2,673,000
553,000
2,772,000
2,724,000
2,839,000
527,000
2,948,000
2,957,000
3,111,000
564,000
3,519,000
3,977,000
4,170,000
845,000
3,965,000
4,058,000
3,396,000
1,414,000
1,414,0003,396,0004,058,0003,965,000845,0004,170,0003,977,0003,519,000564,0003,111,0002,957,0002,948,000527,0002,839,0002,724,0002,772,000553,0002,673,0002,560,0002,461,000478,0002,367,0002,188,0002,116,000515,0002,129,0002,282,0002,027,000623,0001,940,0002,075,0001,929,000634,0001,696,0001,859,0001,824,000588,0001,731,0001,824,0001,563,000474,0001,377,0001,328,0001,278,000544,0001,966,0002,158,0001,115,0001,184,0001,069,0001,090,0001,010,000925,0001,420,0001,117,000979,000893,000000
   > Long-term Assets 
0
0
0
15,519,000
16,253,000
17,433,000
16,342,000
17,142,000
16,764,000
17,157,000
17,871,000
19,170,000
20,860,000
21,791,000
21,604,000
22,551,000
23,044,000
22,716,000
22,490,000
24,786,000
25,628,000
26,038,000
28,134,000
29,869,000
32,344,000
31,758,000
31,619,000
32,253,000
31,861,000
32,821,000
32,940,000
34,648,000
41,341,000
40,098,000
40,227,000
40,529,000
40,093,000
40,695,000
41,130,000
41,913,000
50,027,000
50,078,000
51,579,000
51,742,000
52,631,000
52,401,000
51,488,000
50,874,000
52,273,000
52,754,000
53,747,000
54,501,000
55,112,000
57,294,000
60,885,000
58,136,000
57,451,000
57,108,000
30,493,000
32,764,000
32,764,00030,493,00057,108,00057,451,00058,136,00060,885,00057,294,00055,112,00054,501,00053,747,00052,754,00052,273,00050,874,00051,488,00052,401,00052,631,00051,742,00051,579,00050,078,00050,027,00041,913,00041,130,00040,695,00040,093,00040,529,00040,227,00040,098,00041,341,00034,648,00032,940,00032,821,00031,861,00032,253,00031,619,00031,758,00032,344,00029,869,00028,134,00026,038,00025,628,00024,786,00022,490,00022,716,00023,044,00022,551,00021,604,00021,791,00020,860,00019,170,00017,871,00017,157,00016,764,00017,142,00016,342,00017,433,00016,253,00015,519,000000
       Property Plant Equipment 
0
0
0
3,559,000
3,672,000
3,881,000
3,778,000
3,954,000
3,850,000
3,880,000
3,985,000
4,210,000
4,543,000
4,681,000
4,685,000
4,918,000
4,977,000
4,966,000
4,967,000
5,082,000
6,099,000
6,340,000
6,509,000
6,776,000
7,133,000
7,104,000
7,093,000
7,428,000
7,451,000
7,645,000
7,730,000
8,138,000
9,420,000
9,239,000
9,230,000
9,555,000
9,496,000
9,714,000
9,939,000
10,366,000
16,315,000
16,414,000
16,825,000
17,266,000
17,637,000
17,663,000
17,427,000
17,603,000
17,914,000
17,940,000
18,126,000
18,583,000
18,643,000
19,181,000
19,627,000
18,841,000
18,576,000
18,535,000
10,865,000
10,782,000
10,782,00010,865,00018,535,00018,576,00018,841,00019,627,00019,181,00018,643,00018,583,00018,126,00017,940,00017,914,00017,603,00017,427,00017,663,00017,637,00017,266,00016,825,00016,414,00016,315,00010,366,0009,939,0009,714,0009,496,0009,555,0009,230,0009,239,0009,420,0008,138,0007,730,0007,645,0007,451,0007,428,0007,093,0007,104,0007,133,0006,776,0006,509,0006,340,0006,099,0005,082,0004,967,0004,966,0004,977,0004,918,0004,685,0004,681,0004,543,0004,210,0003,985,0003,880,0003,850,0003,954,0003,778,0003,881,0003,672,0003,559,000000
       Goodwill 
0
0
0
10,356,000
10,930,000
11,902,000
11,104,000
11,464,000
11,052,000
11,399,000
11,886,000
12,669,000
14,275,000
14,892,000
0
15,014,000
15,408,000
15,176,000
14,864,000
14,826,000
16,674,000
16,952,000
18,703,000
19,868,000
21,693,000
21,155,000
21,084,000
21,523,000
20,947,000
21,639,000
21,633,000
22,774,000
26,169,000
25,289,000
25,262,000
25,285,000
24,949,000
25,143,000
25,370,000
25,713,000
27,164,000
27,094,000
27,900,000
27,737,000
28,236,000
27,964,000
27,342,000
26,599,000
27,523,000
27,675,000
28,338,000
28,943,000
29,373,000
30,838,000
33,265,000
31,444,000
31,045,000
30,993,000
15,723,000
15,089,000
15,089,00015,723,00030,993,00031,045,00031,444,00033,265,00030,838,00029,373,00028,943,00028,338,00027,675,00027,523,00026,599,00027,342,00027,964,00028,236,00027,737,00027,900,00027,094,00027,164,00025,713,00025,370,00025,143,00024,949,00025,285,00025,262,00025,289,00026,169,00022,774,00021,633,00021,639,00020,947,00021,523,00021,084,00021,155,00021,693,00019,868,00018,703,00016,952,00016,674,00014,826,00014,864,00015,176,00015,408,00015,014,000014,892,00014,275,00012,669,00011,886,00011,399,00011,052,00011,464,00011,104,00011,902,00010,930,00010,356,000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
803,000
5,000
907
27
6,515
0
0
0
1,134,000
0
0
0
1,304,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000001,304,0000001,134,0000006,515279075,000803,0000000000000000000000000000000000
       Intangible Assets 
0
0
0
1,053,000
1,112,000
1,023,000
927,000
984,000
935,000
908,000
1,001,000
981,000
988,000
1,042,000
0
1,284,000
1,280,000
1,234,000
1,182,000
1,241,000
1,229,000
1,226,000
1,338,000
1,446,000
1,594,000
1,524,000
1,486,000
1,510,000
1,454,000
1,490,000
1,467,000
1,571,000
3,010,000
2,880,000
3,182,000
3,172,000
3,143,000
3,124,000
3,109,000
3,130,000
3,631,000
3,880,000
3,968,000
3,869,000
3,891,000
3,832,000
3,769,000
3,736,000
3,752,000
3,754,000
3,771,000
3,831,000
3,836,000
4,097,000
4,584,000
4,399,000
4,249,000
4,172,000
2,665,000
2,531,000
2,531,0002,665,0004,172,0004,249,0004,399,0004,584,0004,097,0003,836,0003,831,0003,771,0003,754,0003,752,0003,736,0003,769,0003,832,0003,891,0003,869,0003,968,0003,880,0003,631,0003,130,0003,109,0003,124,0003,143,0003,172,0003,182,0002,880,0003,010,0001,571,0001,467,0001,490,0001,454,0001,510,0001,486,0001,524,0001,594,0001,446,0001,338,0001,226,0001,229,0001,241,0001,182,0001,234,0001,280,0001,284,00001,042,000988,000981,0001,001,000908,000935,000984,000927,0001,023,0001,112,0001,053,000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,570,000
1,662,000
1,739,000
1,606,000
2,937,000
866,266
27,287
21,144
29,067
29,641
28,817
2,210,000
3,315,000
3,367,000
3,584,000
2,231,000
2,867,000
2,942,000
2,950,000
2,220,000
3,084,000
3,385,000
3,512,000
2,442,000
3,260,000
3,178,000
3,409,000
0
0
3,408,000
0
0
003,408,000003,409,0003,178,0003,260,0002,442,0003,512,0003,385,0003,084,0002,220,0002,950,0002,942,0002,867,0002,231,0003,584,0003,367,0003,315,0002,210,00028,81729,64129,06721,14427,287866,2662,937,0001,606,0001,739,0001,662,0001,570,0000000000000000000000000000000
> Total Liabilities 
0
0
0
13,230,000
13,866,000
15,272,000
14,213,000
14,733,000
14,784,000
15,205,000
14,658,000
15,744,000
17,713,000
18,534,000
17,693,000
17,508,000
17,581,000
17,602,000
17,299,000
19,026,000
20,205,000
21,302,000
22,247,000
23,733,000
24,990,000
24,591,000
24,140,000
24,220,000
23,478,000
24,258,000
23,891,000
24,843,000
32,497,000
31,877,000
31,930,000
31,413,000
31,482,000
31,713,000
31,725,000
31,695,000
39,155,000
39,547,000
40,063,000
40,426,000
42,016,000
42,302,000
42,120,000
40,623,000
41,452,000
42,524,000
42,895,000
42,674,000
42,530,000
44,079,000
46,172,000
44,197,000
44,380,000
44,983,000
45,046,000
25,633,000
25,633,00045,046,00044,983,00044,380,00044,197,00046,172,00044,079,00042,530,00042,674,00042,895,00042,524,00041,452,00040,623,00042,120,00042,302,00042,016,00040,426,00040,063,00039,547,00039,155,00031,695,00031,725,00031,713,00031,482,00031,413,00031,930,00031,877,00032,497,00024,843,00023,891,00024,258,00023,478,00024,220,00024,140,00024,591,00024,990,00023,733,00022,247,00021,302,00020,205,00019,026,00017,299,00017,602,00017,581,00017,508,00017,693,00018,534,00017,713,00015,744,00014,658,00015,205,00014,784,00014,733,00014,213,00015,272,00013,866,00013,230,000000
   > Total Current Liabilities 
0
0
0
3,528,000
4,830,000
6,321,000
5,435,000
5,711,000
5,428,000
5,741,000
5,152,000
5,988,000
7,845,000
8,013,000
5,882,000
5,198,000
5,906,000
5,802,000
5,444,000
6,023,000
5,697,000
6,034,000
7,286,000
7,104,000
7,650,000
7,409,000
7,102,000
7,409,000
7,399,000
8,057,000
8,450,000
8,544,000
10,184,000
10,369,000
10,647,000
10,665,000
11,248,000
12,123,000
13,296,000
13,275,000
13,672,000
13,745,000
13,780,000
13,884,000
15,990,000
15,443,000
13,855,000
13,216,000
15,947,000
15,204,000
15,352,000
15,062,000
14,138,000
14,300,000
14,862,000
13,658,000
15,919,000
16,057,000
29,189,000
9,330,000
9,330,00029,189,00016,057,00015,919,00013,658,00014,862,00014,300,00014,138,00015,062,00015,352,00015,204,00015,947,00013,216,00013,855,00015,443,00015,990,00013,884,00013,780,00013,745,00013,672,00013,275,00013,296,00012,123,00011,248,00010,665,00010,647,00010,369,00010,184,0008,544,0008,450,0008,057,0007,399,0007,409,0007,102,0007,409,0007,650,0007,104,0007,286,0006,034,0005,697,0006,023,0005,444,0005,802,0005,906,0005,198,0005,882,0008,013,0007,845,0005,988,0005,152,0005,741,0005,428,0005,711,0005,435,0006,321,0004,830,0003,528,000000
       Short-term Debt 
0
0
0
550,000
1,504,000
2,187,000
855,000
2,050,000
1,214,000
1,807,000
1,494,000
2,026,000
3,172,000
3,721,000
1,680,000
794,000
1,412,000
1,453,000
1,240,000
1,852,000
1,354,000
1,381,000
2,203,000
1,758,000
1,742,000
1,564,000
1,237,000
1,162,000
1,466,000
1,841,000
2,122,000
2,059,000
2,443,000
2,791,000
3,003,000
2,899,000
3,434,000
3,993,000
4,954,000
5,094,000
5,420,000
5,627,000
5,307,000
5,508,000
7,397,000
5,578,000
3,729,000
3,670,000
6,116,000
5,274,000
5,049,000
4,772,000
3,934,000
3,734,000
3,366,000
3,036,000
5,061,000
5,020,000
2,346,000
2,581,000
2,581,0002,346,0005,020,0005,061,0003,036,0003,366,0003,734,0003,934,0004,772,0005,049,0005,274,0006,116,0003,670,0003,729,0005,578,0007,397,0005,508,0005,307,0005,627,0005,420,0005,094,0004,954,0003,993,0003,434,0002,899,0003,003,0002,791,0002,443,0002,059,0002,122,0001,841,0001,466,0001,162,0001,237,0001,564,0001,742,0001,758,0002,203,0001,381,0001,354,0001,852,0001,240,0001,453,0001,412,000794,0001,680,0003,721,0003,172,0002,026,0001,494,0001,807,0001,214,0002,050,000855,0002,187,0001,504,000550,000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,670,000
2,045,000
2,385,000
2,043,000
20,211,000
6,020,319
9,950
11,770
15,468
17,972
23,691
2,568,000
4,641,000
4,879,000
4,532,000
4,715,000
6,589,000
4,779,000
2,854,000
2,904,000
5,320,000
4,487,000
4,243,000
3,940,000
3,084,000
2,849,000
2,455,000
2,185,000
4,218,000
4,181,000
2,130,000
2,375,000
2,375,0002,130,0004,181,0004,218,0002,185,0002,455,0002,849,0003,084,0003,940,0004,243,0004,487,0005,320,0002,904,0002,854,0004,779,0006,589,0004,715,0004,532,0004,879,0004,641,0002,568,00023,69117,97215,46811,7709,9506,020,31920,211,0002,043,0002,385,0002,045,0001,670,0000000000000000000000000000000
       Accounts payable 
0
0
0
601,000
583,000
623,000
593,000
693,000
624,000
696,000
619,000
828,000
819,000
823,000
756,000
961,000
835,000
839,000
778,000
885,000
812,000
856,000
903,000
1,052,000
1,136,000
1,036,000
1,029,000
1,291,000
1,033,000
1,084,000
1,040,000
1,315,000
1,409,000
1,437,000
1,400,000
1,688,000
1,479,000
1,527,000
1,574,000
1,823,000
1,760,000
1,719,000
1,665,000
1,905,000
1,819,000
1,664,000
1,690,000
1,816,000
1,635,000
1,669,000
1,649,000
2,039,000
1,897,000
1,929,000
1,926,000
2,070,000
1,998,000
1,925,000
1,217,000
1,488,000
1,488,0001,217,0001,925,0001,998,0002,070,0001,926,0001,929,0001,897,0002,039,0001,649,0001,669,0001,635,0001,816,0001,690,0001,664,0001,819,0001,905,0001,665,0001,719,0001,760,0001,823,0001,574,0001,527,0001,479,0001,688,0001,400,0001,437,0001,409,0001,315,0001,040,0001,084,0001,033,0001,291,0001,029,0001,036,0001,136,0001,052,000903,000856,000812,000885,000778,000839,000835,000961,000756,000823,000819,000828,000619,000696,000624,000693,000593,000623,000583,000601,000000
       Other Current Liabilities 
0
0
0
383,000
2,600,000
483,000
1,066,000
2,968,000
458,000
3,238,000
3,039,000
3,134,000
500,000
3,469,000
2,000
290,000
3,350,000
3,272,000
3,165,000
323,000
3,265,000
3,554,000
3,976,000
388,000
4,575,000
4,647,000
4,684,000
4,761,000
4,634,000
4,922,000
5,026,000
439,000
5,936,000
5,833,000
5,940,000
5,896,000
6,050,000
6,272,000
6,525,000
1,758,000
6,250,000
6,203,000
6,529,000
1,943,000
6,482,000
7,899,000
175,000
2,170,000
7,887,000
7,997,000
8,330,000
2,424,000
8,307,000
8,637,000
9,570,000
7,543,000
8,860,000
8,622,000
5,309,000
4,958,000
4,958,0005,309,0008,622,0008,860,0007,543,0009,570,0008,637,0008,307,0002,424,0008,330,0007,997,0007,887,0002,170,000175,0007,899,0006,482,0001,943,0006,529,0006,203,0006,250,0001,758,0006,525,0006,272,0006,050,0005,896,0005,940,0005,833,0005,936,000439,0005,026,0004,922,0004,634,0004,761,0004,684,0004,647,0004,575,000388,0003,976,0003,554,0003,265,000323,0003,165,0003,272,0003,350,000290,0002,0003,469,000500,0003,134,0003,039,0003,238,000458,0002,968,0001,066,000483,0002,600,000383,000000
   > Long-term Liabilities 
0
0
0
9,702,000
9,036,000
8,951,000
8,778,000
9,022,000
9,356,000
9,464,000
9,506,000
9,756,000
9,868,000
10,521,000
11,811,000
12,310,000
11,675,000
11,800,000
11,855,000
13,003,000
14,508,000
15,268,000
14,961,000
16,629,000
17,340,000
17,182,000
17,038,000
16,811,000
16,079,000
16,201,000
15,441,000
16,299,000
22,313,000
21,508,000
21,283,000
20,748,000
20,234,000
19,590,000
18,429,000
18,420,000
25,483,000
25,802,000
26,283,000
26,542,000
26,026,000
26,859,000
28,265,000
27,407,000
25,505,000
27,320,000
27,543,000
27,612,000
28,392,000
29,779,000
31,310,000
30,539,000
28,461,000
28,926,000
15,857,000
16,303,000
16,303,00015,857,00028,926,00028,461,00030,539,00031,310,00029,779,00028,392,00027,612,00027,543,00027,320,00025,505,00027,407,00028,265,00026,859,00026,026,00026,542,00026,283,00025,802,00025,483,00018,420,00018,429,00019,590,00020,234,00020,748,00021,283,00021,508,00022,313,00016,299,00015,441,00016,201,00016,079,00016,811,00017,038,00017,182,00017,340,00016,629,00014,961,00015,268,00014,508,00013,003,00011,855,00011,800,00011,675,00012,310,00011,811,00010,521,0009,868,0009,756,0009,506,0009,464,0009,356,0009,022,0008,778,0008,951,0009,036,0009,702,000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,993,000
2,559,000
2,544,000
3,154,000
4,545,000
1,326,762
42,469
40,868
42,193
41,427
38,815
4,380,000
4,525,000
4,550,000
4,577,000
4,792,000
4,866,000
4,950,000
4,998,000
5,164,000
5,113,000
5,305,000
5,401,000
5,229,000
5,115,000
5,145,000
6,069,000
0
0
0
0
0
000006,069,0005,145,0005,115,0005,229,0005,401,0005,305,0005,113,0005,164,0004,998,0004,950,0004,866,0004,792,0004,577,0004,550,0004,525,0004,380,00038,81541,42742,19340,86842,4691,326,7624,545,0003,154,0002,544,0002,559,0002,993,0000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
950,000
864,000
865,000
986,000
200,000
53,820
4,673
5,317
5,411
5,167
5,012
640,000
638,000
677,000
698,000
665,000
0
0
0
681,000
0
0
0
708,000
0
0
0
0
0
0
0
0
00000000708,000000681,000000665,000698,000677,000638,000640,0005,0125,1675,4115,3174,67353,820200,000986,000865,000864,000950,0000000000000000000000000000000
> Total Stockholder Equity
0
0
0
4,270,000
4,526,000
4,741,000
4,725,000
4,965,000
4,964,000
4,921,000
5,699,000
5,971,000
6,090,000
7,315,000
7,502,000
7,633,000
7,940,000
7,811,000
7,846,000
8,195,000
8,437,000
8,511,000
9,150,000
9,335,000
10,287,000
10,164,000
10,384,000
10,935,000
11,039,000
11,311,000
11,745,000
12,503,000
13,525,000
13,076,000
13,221,000
13,661,000
13,884,000
14,381,000
14,816,000
15,411,000
16,002,000
15,880,000
16,670,000
16,778,000
17,179,000
17,473,000
16,901,000
16,949,000
17,807,000
17,699,000
18,301,000
18,998,000
19,870,000
20,664,000
21,382,000
20,415,000
20,532,000
20,086,000
20,034,000
18,999,000
18,999,00020,034,00020,086,00020,532,00020,415,00021,382,00020,664,00019,870,00018,998,00018,301,00017,699,00017,807,00016,949,00016,901,00017,473,00017,179,00016,778,00016,670,00015,880,00016,002,00015,411,00014,816,00014,381,00013,884,00013,661,00013,221,00013,076,00013,525,00012,503,00011,745,00011,311,00011,039,00010,935,00010,384,00010,164,00010,287,0009,335,0009,150,0008,511,0008,437,0008,195,0007,846,0007,811,0007,940,0007,633,0007,502,0007,315,0006,090,0005,971,0005,699,0004,921,0004,964,0004,965,0004,725,0004,741,0004,526,0004,270,000000
   Common Stock
0
0
0
161,000
161,000
162,000
162,000
162,000
162,000
163,000
163,000
163,000
163,000
177,000
178,000
178,000
178,000
178,000
179,000
180,000
180,000
180,000
181,000
542,000
543,000
544,000
545,000
546,000
546,000
546,000
547,000
547,000
553,000
554,000
555,000
555,000
555,000
556,000
556,000
556,000
556,000
557,000
557,000
557,000
557,000
557,000
557,000
557,000
557,000
558,000
558,000
558,000
558,000
563,000
563,000
563,000
563,000
563,000
563,000
563,000
563,000563,000563,000563,000563,000563,000563,000558,000558,000558,000558,000557,000557,000557,000557,000557,000557,000557,000557,000556,000556,000556,000556,000555,000555,000555,000554,000553,000547,000547,000546,000546,000546,000545,000544,000543,000542,000181,000180,000180,000180,000179,000178,000178,000178,000178,000177,000163,000163,000163,000163,000162,000162,000162,000162,000161,000161,000000
   Retained Earnings Total Equity000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,663,000
407,000
146,000
110,000
430,000
18,000
18,000430,000110,000146,000407,0001,663,000000000000000000000000000000000000000000000000000000000
   Capital Surplus 000000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
4,109,000
4,365,000
4,579,000
4,563,000
4,768,000
4,902,000
4,900,000
5,612,000
5,808,000
5,934,000
7,138,000
7,262,000
7,583,000
7,805,000
7,767,000
7,889,000
8,366,000
8,630,000
8,698,000
9,008,000
8,912,000
9,259,000
9,363,000
9,735,000
10,109,000
10,467,000
10,552,000
10,988,000
11,432,000
12,402,000
12,576,000
12,985,000
13,504,000
13,952,000
14,214,000
14,659,000
15,185,000
15,604,000
15,550,000
15,960,000
16,411,000
16,770,000
17,172,000
17,107,000
17,527,000
17,961,000
17,141,000
17,743,000
18,440,000
19,312,000
20,101,000
4,319,000
4,323,000
4,321,000
4,323,000
4,325,000
4,326,000
4,326,0004,325,0004,323,0004,321,0004,323,0004,319,00020,101,00019,312,00018,440,00017,743,00017,141,00017,961,00017,527,00017,107,00017,172,00016,770,00016,411,00015,960,00015,550,00015,604,00015,185,00014,659,00014,214,00013,952,00013,504,00012,985,00012,576,00012,402,00011,432,00010,988,00010,552,00010,467,00010,109,0009,735,0009,363,0009,259,0008,912,0009,008,0008,698,0008,630,0008,366,0007,889,0007,767,0007,805,0007,583,0007,262,0007,138,0005,934,0005,808,0005,612,0004,900,0004,902,0004,768,0004,563,0004,579,0004,365,0004,109,000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.




Income Statement

Currency in EUR. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue22,299,000
Cost of Revenue-17,241,000
Gross Profit5,058,0005,058,000
 
Operating Income (+$)
Gross Profit5,058,000
Operating Expense-3,762,000
Operating Income1,296,0001,296,000
 
Operating Expense (+$)
Research Development608,000
Selling General Administrative2,405,000
Selling And Marketing Expenses750,000
Operating Expense3,762,0003,763,000
 
Net Interest Income (+$)
Interest Income118,000
Interest Expense-530,000
Other Finance Cost-4,000
Net Interest Income-416,000
 
Pretax Income (+$)
Operating Income1,296,000
Net Interest Income-416,000
Other Non-Operating Income Expenses-
Income Before Tax (EBT)727,0001,865,000
EBIT - interestExpense = 766,000
-117,000
-64,000
Interest Expense530,000
Earnings Before Interest and Taxes (EBIT)1,296,0001,257,000
Earnings Before Interest and Taxes (EBITDA)2,774,000
 
After tax Income (+$)
Income Before Tax727,000
Tax Provision-477,000
Net Income From Continuing Ops238,000250,000
Net Income-594,000
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses21,003,000
Total Other Income/Expenses Net-569,000416,000
 

Technical Analysis of Fresenius
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Fresenius. The general trend of Fresenius is BEARISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Fresenius's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-28.6%) Bearish trend (28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Fresenius SE & Co KGaA ADR.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 7.36 < 7.52 < 7.52.

The bearish price targets are: 7.0486 > 6.61 > 6.57.

Tweet this
Fresenius SE & Co KGaA ADR Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Fresenius SE & Co KGaA ADR. The current mas is .

The long score for the Moving Averages is 5/14.
The longshort score for the Moving Averages is -4/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Fresenius SE & Co KGaA ADR Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Fresenius SE & Co KGaA ADR. The current macd is 0.04688233.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Fresenius price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Fresenius. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Fresenius price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Fresenius SE & Co KGaA ADR Daily Moving Average Convergence/Divergence (MACD) ChartFresenius SE & Co KGaA ADR Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Fresenius SE & Co KGaA ADR. The current adx is 16.82.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Fresenius shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Fresenius SE & Co KGaA ADR Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Fresenius SE & Co KGaA ADR. The current sar is 6.73958418.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Fresenius SE & Co KGaA ADR Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Fresenius SE & Co KGaA ADR. The current rsi is 60.41. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending down: The RSI is trending down. -1
Fresenius SE & Co KGaA ADR Daily Relative Strength Index (RSI) ChartFresenius SE & Co KGaA ADR Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Fresenius SE & Co KGaA ADR. The current phase is Overbought in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Fresenius price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Fresenius SE & Co KGaA ADR Daily Stochastic Oscillator ChartFresenius SE & Co KGaA ADR Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Fresenius SE & Co KGaA ADR. The current cci is 174.07.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Fresenius SE & Co KGaA ADR Daily Commodity Channel Index (CCI) ChartFresenius SE & Co KGaA ADR Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Fresenius SE & Co KGaA ADR. The current cmo is 30.11.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Fresenius SE & Co KGaA ADR Daily Chande Momentum Oscillator (CMO) ChartFresenius SE & Co KGaA ADR Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Fresenius SE & Co KGaA ADR. The current willr is -15.625.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Fresenius SE & Co KGaA ADR Daily Williams %R ChartFresenius SE & Co KGaA ADR Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Fresenius SE & Co KGaA ADR.

Fresenius SE & Co KGaA ADR Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Fresenius SE & Co KGaA ADR. The current atr is 0.13504726.

Fresenius SE & Co KGaA ADR Daily Average True Range (ATR) ChartFresenius SE & Co KGaA ADR Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Fresenius SE & Co KGaA ADR. The current obv is -4,775,990.

Fresenius SE & Co KGaA ADR Daily On-Balance Volume (OBV) ChartFresenius SE & Co KGaA ADR Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Fresenius SE & Co KGaA ADR. The current mfi is 83.14.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
Fresenius SE & Co KGaA ADR Daily Money Flow Index (MFI) ChartFresenius SE & Co KGaA ADR Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Fresenius SE & Co KGaA ADR.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-28STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-01MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-11CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-22WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-11WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-16BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-31WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-15CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-21WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-07CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-13CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-21WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-25BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-05WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-16CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-18STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Fresenius SE & Co KGaA ADR Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Fresenius SE & Co KGaA ADR based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5060.409
Ma 20Greater thanMa 506.823
Ma 50Greater thanMa 1006.884
Ma 100Greater thanMa 2007.211
OpenGreater thanClose7.106
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Fresenius with someone you think should read this too:
  • Are you bullish or bearish on Fresenius? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Fresenius? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Fresenius SE & Co KGaA ADR

I send you an email if I find something interesting about Fresenius SE & Co KGaA ADR.


Comments

How you think about this?

Leave a comment

Stay informed about Fresenius SE & Co KGaA ADR.

Receive notifications about Fresenius SE & Co KGaA ADR in your mailbox!